The incidence of hepatocellular carcinoma has risen between 2010 and 2019; however, for people under 50 years of age, the proportion of cases has declined.

Epkinly with Rituxan and Revlimid, compared to Rituxan and Revlimid alone, reduced risk of progression or death by 79%.

Xu discussed the benefit of using biomarkers to more precisely guide treatment for patients with renal cell carcinoma.

I wrote a poem about life with endometrial cancer, rejecting pity and embracing strength, connection and the dignity of being ...

Among individuals who receive a cancer diagnosis, entering into the survivorship period can be one of the most ...

Dena Paluck became a mentor to other parents after guiding her daughter through osteosarcoma treatment and feeling isolated ...

I survived peritoneal mesothelioma thanks to the love, prayers, and support of family, friends, and strangers who reminded me ...

In a phase 3 trial, 72.2% of patients with recurrent low-grade bladder cancer kept complete response at 24 months after ...

An artificial intelligence-based image analysis model has more accurately predicted cancer biomarkers and outcomes compared with conventional methods.

Getting an expert opinion is essential after a rare cancer diagnosis like GIST, as each patient’s situation is unique, ...

Staci Kirk, a six-time cancer survivor, founded the Stiletto Boss Foundation to empower women through mentorship, ...

In an interview with CURE, Clara Cirk shares the emotional weight of finishing chemo while facing ongoing immunotherapy and ...